Navigation Links
Prospective in Medical Technology

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

... References: (1) Soriano, V et al., prospective comparison of Nevirapine and Atazanavir/ritonavir ... Data on File (3) Soriano, V et al., prospective comparison of Nevirapine and Atazanavir/ritonavir ... Poster LBPEB07. (4) Soriano, V et al., prospective comparison of Nevirapine and Atazanavir/ritonavir ...

MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants

... prospective Study Seeks to Assess RSV Burden in Outpatient ... today's announcement of the first observational prospective study designed to assess the burden of ... disease. "The intent of this first-of-its-kind prospective study is to add to the body of evidence ...

Vermillion Presents Critical Data From Its OVA1 Clinical Trial

... diagnostics company, presented data from its prospective OVA1 clinical trial at the Society of Gynecologic ... pleased with the significant results of the OVA1 prospective clinical trial. A major strength of the OVA1 prospective clinical trial was its inclusion of patients seen ...

PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C

... - Largest prospective study in under-treated and under-studied ... results from the LATINO study, the largest prospective study to evaluate the response of Latino whites ... to conduct a study like LATINO, the first ever prospective trial evaluating hepatitis C treatment response ...

CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema

... trial I.M.P.A.C.T. (International Multi-centre prospective Angioedema C1-inhibitor Trial), showed that ... trial. I.M.P.A.C.T. is a multi-center, prospective clinical trial conducted globally in more than 45 ... of the disease. I.M.P.A.C.T. evaluated in a prospective and double-blind fashion whether different doses ...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

... the process of recruiting approximately 20 clinical sites for the AIGIS prospective Registry, which will follow AIGIS patients for 12 months and compare the ... Additional information regarding TYRX, Inc.'s Retrospective and prospective Registries, and associated clinical results, can be found at ...

AACR Data Highlights InNexus Preclinical Antibody Candidate

... new data on its lead preclinical candidate DXL625 (CD20) for the prospective treatment of Non Hodgkin's Lymphoma (NHL) at the annual meeting of the ... data on DXL625 indicates the strong promise of this candidate as a prospective treatment for NHL and Chronic Lymphatic Leukemia (CLL), and we anticipate ...

BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

... 125 Patient, prospective Randomized Placebo-Controlled Phase II Study Shows Statistically ... National Cancer Institute (NCI) in the US. The results from the Phase II prospective randomized placebo-controlled study of 125 patients with advanced prostate ...

Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

... KVISTGÃ…RD, Denmark, October 7 /PRNewswire-FirstCall/ -- - 125 Patient, prospective Randomized Placebo-Controlled Phase II Study Shows Statistically ... National Cancer Institute (NCI) in the US. The results from the Phase II prospective randomized placebo-controlled study of 125 patients with advanced prostate ...

Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University

... at The Johns Hopkins University are participating in a large multi-center prospective trial to study the link between the IGF2 biomarker and colorectal cancer. ... risk marker shown in earlier clinical studies is confirmed by the large prospective trial now underway, it can potentially change the way populations are ...

Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma

... the June 2008 issue of Current Medical Research and Opinion. This large prospective trial, which followed 475 patients who received either twice-daily Advair ... powder) or twice-daily Flovent Diskus 100mcg for a year, was the first prospective study to assess the addition of a LABA to an ICS compared to ICS alone in ...

Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer

... academic institutions are collaborating on an 800-patient, multi-center, prospective study of the effectiveness of cryoablation on men whose prostate cancer ... to normal activity within a few days. The SCORE Study is the largest prospective trial ever undertaken in cryoablation. Investigators will collect uniform, ...

New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... implications of these policy changes by evaluating data from an ongoing prospective registry of ESA-treated patients in 55 U.S. oncology clinics between ... ESAs at different baseline Hb levels. Observational data from an ongoing, prospective registry of 1,059 ESA-treated patients in 59 U.S. oncology clinics from ...

Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients

... management of risk for infection BOSTON, April 10 /PRNewswire/ -- A prospective analysis of data collected from 170 patients receiving lung ... low ImmuKnow values in an earlier study, we now have specific preliminary prospective evidence that will guide us in predicting risk for fungal infection in ...

New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes

... Effect on Regression of Intravascular Sonographic Coronary Obstruction prospective Evaluation) trial. The PERISCOPE trial was presented today as a late ... than 16,000 patients, including short- and long-term trials, as well as prospective and observational studies, have shown no evidence that ACTOS is associated ...

Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood

... disorder that can occur as patients age. Additionally, retrospective and prospective trials among Florida Medicaid populations and patients in Nigeria, an area ... Center for Sickle Cell Disease, Howard University, Washington, DC This prospective trial included interviews with 206 adult and pediatric sickle cell ...

New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence

... women's health, announced today that six month data from its post-market, prospective open label study to evaluate the long term durability of the Renessa(R) ... improvement in their quality of life "This multi-center three year prospective trial is expected to confirm the outcomes seen in our previous U.S. ...

Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing

... We find it validating to identify the possibility, in a large, prospective clinical trial, that patients can test their Haptoglobin type and then ... with Clalit Health Services, the largest health plan in Israel, in a large prospective clinical trial that provides strong support for the claim that Vitamin E ...

Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C

... click here. To view the AASLD poster presentation reporting results of a prospective comparison of commercial fibrosis serum marker panels (Patel, et al), ... for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these ...

Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy

... click here. To view the AASLD poster presentation reporting results of a prospective comparison of commercial fibrosis serum marker panels (Patel, et al), ... for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these ...

Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C

... click here. To view the AASLD poster presentation reporting results of a prospective comparison of commercial fibrosis serum marker panels (Patel, et al), ... for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these ...

Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting

... will present the final results from the POWeR (Peginterferon alfa-2b prospective Optimal Weight-based Dosing Response) program, a large observational study ... with Normal ALT Treated with Pegylated Interferon Alfa-2b and Ribavirin: A prospective Study; P. Deltenre et al., Abstract 312, Saturday, Nov. 3, 2:00 pm, ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... colorectal cancer," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen. "These are the first prospective Phase 3 data to demonstrate the utility of KRAS mutational analysis as a predictive biomarker." Overall, the adverse event profile was as ...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... (as indicated by the NIHSS), and male gender were identified. According to Nogueira, the study serves as preliminary data for DAWN, a prospective randomized trial designed to assess the benefit of this approach as compared to standard medical therapy. "We look forward to exploring this ...

Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression

... stem cells in the hippocampus of the adult brain produce new brain cells, including neurons. "Our study results provide the first prospective clinical validation of neurogenesis as a target for the treatment of mood disorders like depression, in contrast to the traditional focus on ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders

... "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or ...

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

... to conduct research and development and to expand commercialisation activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any ...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

... pertaining to King's planned presentations; statements pertaining to the Company's expectations for its novel pain treatment candidates and potential prospective physician utilization of these candidates; and statements pertaining to the Company's expectations regarding the FDA's review of the Company's NDAs ...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

... minimally invasive vein harvesting," said lead investigator Robert Poston, M.D., Chief, Division of Cardiac Surgery, Boston University . The prospective study examined acute patency rates in 460 patients that underwent OPCAB using veins acquired through EVH, comparing patients receiving no heparin ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... sulfonylurea in the ADOPT study. Although RECORD was not designed to study microvascular endpoints, previous studies such as the United Kingdom prospective Diabetes Study, which studied other medicines, have found that improved glycaemic control may reduce complications of diabetes that can lead to ...

Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons

... series reported to date, "Radiofrequency Ablation for Eradication of Barrett's Esophagus Containing High-Grade Dysplasia or Early Cancer: A prospective Series of 73 Patients," researchers combined a baseline focal endoscopic resection for disease staging, and then applied serial RFA with the HALO ...

Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barrett's Esophagus

... that ablative therapy can be delivered by the expert endoscopist in the community setting, with an expectation for comparable results as seen in prospective trials from tertiary referral centers." About BARRX Medical, Inc. BARRX Medical, Inc. develops treatment solutions for Barrett's ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... the patients receiving Sandostatin LAR versus 7.2 months in the placebo group (P<0.0001)(1). The trial, called PROMID ( P lacebo-controlled prospective R andomized study on the antiproliferative efficacy of O ctreotide LAR in patients with metastatic neuroendocrine MID gut tumors), is a Phase IIIb ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... reported in the Phase II study include nausea, vomiting, headache, back pain, and cough. For a more complete listing of potential side effects, prospective clinical trial participants should refer to the informed consent document. About Lilly Biotech Efforts Lilly is the 5th largest ...

Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

... meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences ...

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

... Genous treated patients were relatively stable between one and two years," said Beijk. TRIAS HR is a randomized, 193-patient, single-center, prospective study involving patients with a high risk of restenosis. High risk of restenosis is defined as patients who have diabetes mellitus and/or small ...

PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009

... . This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar ...

Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity

... baseline BMI of the study population was 36.3 kg/m2 and baseline weight was 101.3 kg. The study was a randomized, double-blind, placebo-controlled, prospective trial with subjects randomized to receive once-a-day treatment with mid-dose Qnexa (7.5 mg phentermine/46 mg topiramate CR), full-dose Qnexa (15 mg ...
Other Contents
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... in microcontroller (MCU) and touch technology solutions, today launched ... sensors with the widest V cc range ... temperature accuracy and faster I 2 C bus communication ... serial EEPROM memory making them ideal for consumer, industrial, ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/22/2014)... recognition of Veteran’s Day, Discount Labels contributed a portion ... that provides services to veterans and their families, free ... hundred acres in the hills of Southern Indiana, the ... hiking, horseback riding, 4-wheeling, skeet shooting, and much more. ... U.S. Service men and women, police officers, fire fighters ...
(Date:12/22/2014)... Pasadena sleep apnea dentist, Dr. Marine ... drivers are 15 times more likely to cause deadly ... experts believe that sleep-deprived drivers may be just as ... of Americans may be sleep-deprived without even knowing it. ... 18 million Americans have sleep apnea, but as many ...
(Date:12/22/2014)... 22, 2014 7,178 small business owners ... Black Friday shopping and opted instead to join Digital ... company, for their 5th annual “Black Friday Boot Camp”. ... $7 to attend the 5 hour online training event ... donated to support two Central Texas based charities dedicated ...
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again ... provide logistics and support for one of Dallas’ largest holiday ... history of giving back to the community in which it ... Drive were Whataburger® and 99.5 The Wolf. , There is ... gifts to children who would otherwise not receive any is ...
(Date:12/22/2014)... 22, 2014 NAPW honors ... Woman of the Year. Ms. Foley is recognized with ... largest, most-recognized networking organization of professional women in the ... Association of Professional Women is a powerfully vibrant networking ... Chapters. , “As a nurse, I felt like I ...
Breaking Medicine News(10 mins):Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2
Other TagsOther Tags